In addition, several clinical studies have also confirmed the beneficial effects of the local application of VEGFA, which has been shown to improve myocardial perfusion and function with sustained symptomatic relief in end‐stage angina pectoris.36, 37. The gene discussed is VEGFA; the disease is angina pectoris.